The Sepsis Bundle and the Hypotensive Patient Who 'Looks Fine'
A 71-year-old woman with hypertension and CKD stage 3 (baseline creatinine 1.6 mg/dL) presents with 2 days of dysuria and confusion. Initial vitals: T 38.6°C, HR 112, BP 96/58, RR 22, SpO2 94% on room air. She is conversant but slow to answer; mucous membranes dry; lungs clear; no edema. Lactate is 3.4 mmol/L. Urinalysis shows nitrites, leukocyte esterase, and WBCs. You initiate the sepsis pathway: cultures, antibiotics, and a 30 mL/kg crystalloid bolus (she weighs 68 kg, so ~2,000 mL). After 1,500 mL she remains at BP 92/54, HR 108, and her oxygen requirement has risen to 4 L nasal cannula. A colleague suggests stopping fluids and starting norepinephrine; another says 'finish the bolus, the bundle says 30 mL/kg.'
1. How do you reconcile the 30 mL/kg recommendation with this patient's response so far?
Read the worked answer
The 30 mL/kg figure is an initial resuscitation anchor, not a mandate to be completed regardless of physiology. The Surviving Sepsis Campaign suggests an initial 30 mL/kg of crystalloid within the first 3 hours for sepsis-induced hypoperfusion or septic shock, but explicitly frames it as a starting point with reassessment.
Reassess with dynamic measures, not a single number:
- Bedside exam: rising oxygen requirement and new tachypnea suggest she may be developing fluid intolerance / pulmonary congestion, especially with CKD.
- Consider dynamic assessment: passive leg raise, stroke volume/pulse pressure variation if available, or a focused cardiac ultrasound. Static CVP is unreliable.
- Trend lactate and mental status as perfusion markers.
Decision: You are not obligated to push the remaining 500 mL blindly. A reasonable approach is to give a small, reassessed aliquot (e.g., 250 mL) with immediate re-evaluation, or stop crystalloid and start a vasopressor if she remains hypotensive with signs of intolerance. Both are defensible; the indefensible move is completing a volume target while ignoring new hypoxia.
Exam point: The bundle is a floor, not a ceiling, and the patient's response outranks the protocol. Document the reassessment that justified your deviation.
2. What is your vasopressor plan, and what monitoring and access considerations apply given her CKD?
Read the worked answer
First-line: norepinephrine. Start it early in septic shock that persists after initial fluids; do not delay it to complete a fluid number. Titrate to a MAP goal (typically ≥65 mmHg, individualized higher if she has chronic hypertension and evidence of hypoperfusion).
Access and safety:
- Peripheral initiation of norepinephrine is acceptable in many protocols via a well-positioned, proximal large-bore line with frequent site checks; central access is preferred for prolonged or high-dose infusion. Don't let central line placement delay the drug.
- Add vasopressin if norepinephrine requirements escalate (typically ~0.25–0.5 mcg/kg/min range per protocol).
CKD-specific considerations:
- Avoid nephrotoxins; dose-adjust antibiotics to renal function (e.g., avoid or adjust aminoglycosides; adjust vancomycin and beta-lactams).
- Monitor urine output and creatinine; the choice of crystalloid (balanced vs. saline) matters at high volumes - large saline loads can cause hyperchloremic acidosis.
- Reassess volume status frequently; she is at risk for both under- and over-resuscitation.
Exam point: The answer that starts pressors while continuing to reassess, with attention to renal dosing, beats both 'finish the bolus first' and 'stop everything and go straight to pressors with no further thought.'